Aron-Wisnewsky J, et al. - Goal of this work was to establish an improved scoring system for predicting diabetes remission following RYGB (the Advanced-DiaRem [Ad-DiaRem]). Researchers offer the Ad-DiaRem, which includes two additional clinical variables, as an optimised tool with enhanced accuracy to predict diabetes remission 1 year post-RYGB. In addition, this tool might be useful for personalised management of individuals with diabetes when considering bariatric surgery in routine care, ultimately contributing to precision medicine.